Spots Global Cancer Trial Database for Noninvasive Assessment of Lymphedema Among Breast Cancer Survivors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Noninvasive Assessment of Lymphedema Among Breast Cancer Survivors
Official Title: A Pilot Study of Noninvasive Assessment of Lymphedema Among Breast Cancer Survivors
Study ID: NCT05278871
Interventions
Study Description
Brief Summary: This proof of concept study will evaluate the ability of a new, ultrasound based technology called Bullseye Constructive Shearwave Interference (CSI) (trade name, Bullseye Elasticity Quantification) to measure lymphedema of the upper arm among breast cancer survivors. The study's hypothesis is that the CSI device can detect the presence of clinically significant lymphedema when compared with the standard arm tape measurement.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Durham Regional Hospital, Durham, North Carolina, United States
Duke University Medical Center, Durham, North Carolina, United States
Contact Details
Name: Susan McDuff, MD PhD
Affiliation: Duke Health
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
